Buscar en
Enfermedades Infecciosas y Microbiología Clínica
Toda la web
Inicio Enfermedades Infecciosas y Microbiología Clínica Prevención de la infección perinatal por estreptococo del grupo B. Recomendaci...
Información de la revista
Vol. 21. Núm. 8.
Páginas 417-423 (Enero 2003)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 21. Núm. 8.
Páginas 417-423 (Enero 2003)
DOI: 10.1016/S0213-005X(03)72979-6
Acceso a texto completo
Prevención de la infección perinatal por estreptococo del grupo B. Recomendaciones españolas revisadas
Visitas
...
Sociedad Española de Obstetricia y Ginecología (Sego) , Sociedad Española de Neonatología (Sen) , Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (Seimc) , Sociedad Española de Quimioterapia (Seq) , Sociedad Española de Medicina Familiar y Comunitaria (Semfyc) , M. de la Rosa1
Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
Sociedad Española de Obstetricia y Ginecología. Recomendaciones para la prevención de la infección perinatal por estreptococo del grupo B.
Prog Obstet Gynecol, 41 (1998), pp. 431-435
[2.]
A. Andreu, I. Sanfeliu, L. Viñas, M. Barranco, J. Bosch, E. Dopico, et al.
Declive de la Incidencia de la sepsis perinatal por estreptococo del grupo B-Barcelona 1994-2001-Relación con las políticas profilácticas.
Enferm Infec Microbiol Clin, 21 (2003), pp. 174-179
[3.]
López JB, Sastre Sánchez M, Luna M, Fernández Colomer B, Coto Cotallo G.D. “Grupo de Hospitales Castrillo”. Impact of antimicrobial prophylaxis in the epidemiology of vertical transmission sepsis. GBS neonatal disease symposium. Granada november 2002
[4.]
M. De Cueto, M. de la Rosa-Fraile.
Prevención de la infección neonatal por Streptococcus agalactiae. Un tema consolidado.
Enferm Infecc Microbiol Clin, 21 (2003), pp. 171-173
[5.]
De Cueto M, de la Rosa-Fraile M. Prevention of perinatal group B streptococcal disease. Revised Guidelines from CDC. 2002 MMWR 51(RR11):1-22.
[6.]
C.J. Baker, M.S. Edwards.
Streptococcus agalactiae (group B streptococcus).
Principles and Practice of Infectious Diseases, 5th, pp. 2156-2167
[7.]
A. Schuchat.
Group B streptococcus.
[8.]
M.S. Edwards, C.J. Baker.
Group B streptococcal infections.
Infectious Diseases of the Fetus & Newborn Infant, 5th, pp. 1091-1156
[9.]
J. Bosch, A. Pericot, M. Amorós, R. Ros.
Endometritis puerperal: estudio de 52 casos con diagnóstico clínico y microbiológico.
Enferm Infec Microbiol Clin, 13 (1995), pp. 203-208
[10.]
M.K. Yancey, P. Duff, P. Clark, T. Kurtzer, B.H. Frentzen, P. Kubilis.
Peripartum infection associated with vaginal group B streptococcal colonization.
Obstet Gynecol, 84 (1994), pp. 816-819
[11.]
D.R. Feikin, P. Thorsen, S. Zywicki, M. Arpi, J.G. Westergaard, A. Schuchat.
Association between colonization with group B streptococci during pregnancy and preterm delivery among Danish women.
Am J Obstet Gynecol, 184 (2001), pp. 427-433
[12.]
R. Matorras, A. Garcia Perea, F. Omeñaca, J.A. Usandizaga, A. Nieto, R. Herruzo.
Group B Streptococcus and premature rupture of membranes and preterm delivery.
Gynecol Obstet Invest, 27 (1989), pp. 14-18
[13.]
J.A. Regan, M.A. Klebanoff, R.P. Nugent, D.A. Eschenbach, W.C. Blackwelder, Y.S. Yu Lou, et al.
Colonization with group B streptococci in pregnancy and adverse outcome.
Am J Obstet Gynecol, 174 (1996), pp. 1354-1360
[14.]
M. MØller, A.C. Thomsen, K. Borch, K. Dinesen, M. Zdravkovic.
Rupture of membranes and premature delivery associated with group B streptococci in urine of pregnant women.
Lancet, 2 (1984), pp. 69-70
[15.]
T. Juncosa, J. Bosch, E. Dopico, C. Guardia, J. Lite, M. Sierra, et al.
Infección neonatal por Streptococcus agalactiae. Estudio multicéntrico en el área de Barcelona.
Enf Infec Microbiol Clin, 16 (1998), pp. 312-315
[16.]
J.B. López Sastre, G.D. Coto Cotallo, B. Fernández Colomer.
Neonatal sepsis of vertical transmission: An epidemiological study from the “Grupo de Hospitales Castrillo”.
J Perinat Med, 28 (2000), pp. 309-315
[17.]
S.J. Schrag, S. Zywicki, M.M. Farley, A.L. Reingold, L.H. Harrison, L.B. Lefkowitz, et al.
Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis.
N Engl J Med, 342 (2000), pp. 15-20
[18.]
S.J. Bliss, S.D. Manning, P. Tallman, C.J. Baker, M.D. Pearlman, C.F. Marrs, et al.
Group B streptococcus colonization in male and nonpregnant female university students: A cross-sectional prevalence study.
Clin Infect Dis, 15 (2002), pp. 184-190
[19.]
J.A. Regan, A. Klebanoff, R.P. Nugent.
Vaginal Infection and Prematurity Study Group. The epidemiology of group B colonization in pregnancy.
Obstet Gynecol, 77 (1991), pp. 604-610
[20.]
A. Andreu, M. Barranco, J. Bosch, E. Dopico, C. Guardia, T. Juncosa, et al.
Prevention of perinatal group B streptococcal disease in Europe.
Scand J Infect Dis, 29 (1997), pp. 532
[21.]
M. Cueto, M.J. Sánchez, A. Sampedro, J.A. Miranda, A.J. Herruzo, M de la Rosa-Fraile.
Timing of intrapartum ampicillin and prevention of vertical transmission of group B streptococcus.
Obstet Gynecol, 91 (1998), pp. 112-114
[22.]
A. Mazon, M.S. Salvo, R. Ezcurra.
Resultados del programa de prevención de la infección neonatal por estreptococo del grupo B.
Prog Obstet Gynecol, 43 (2000), pp. 233-236
[23.]
K. Persson, B. Bjerre, L. Elfstrom, S. Polberger, A. Forsgren.
Group B streptococci at delivery: High counts in urine increases risk for neonatal colonization.
Scand J Infect Dis, 18 (1986), pp. 525-531
[24.]
S.J. Schrag, E.R. Zell, R. Lynfield, A. Roome, K.E. Arnold, A.S. Craig, et al.
A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates.
N Engl J Med, 347 (2002), pp. 233-239
[25.]
M.K. Yancey, A. Schuchat, L.K. Brown, V.l. Ventura, G.R. Markenson.
The accuracy of late antenatal screening cultures in predicting genital group B streptococcal colonization at delivery.
Obstet Gynecol, 88 (1996), pp. 811-815
[26.]
U.D. Allen, L. Navas, S.M. King.
Effectiveness of intrapartum penicillin prophylaxis in preventing early-onset group B streptococcal infection: Results of a meta-analysis.
Can Med Assoc J, 149 (1993), pp. 1659-1665
[27.]
K.M. Boyer, S.P. Gotoff.
Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis.
N Engl J Med, 314 (1986), pp. 1665-1669
[28.]
S.M. Garland, J.R. Fliegner.
Group B streptococcus (GBS) and neonatal infections: The chase for intrapartum chemoprophylaxis.
Aust N Z Obstet Gynaecol, 31 (1991), pp. 119-122
[29.]
S.E. Gardner, M.D. Yow, L.J. Leeds, P.K. Thompson, E.O. Jr. Mason, D.J. Clark.
Failure of penicillin to eradicate group B streptococcal colonization in the pregnant woman. A couple study.
Am J Obstet Gynecol, 35 (1979), pp. 1062-1065
[30.]
R.T. Hall, W. Barnes, L. Krishnan, D.J. Harris, P.G. Rhodes, J. Fayez, et al.
Antibiotic treatment of parturient women colonized with group B streptococci.
Am J Obstet Gynecol, 124 (1976), pp. 630-634
[31.]
E.M. Levine, C.M. Strom, V. Ghai, J.J. Barton.
Intrapartum management relating to risk of perinatal transmission of group B streptococcus.
Infect Dis Obstet Gynecol, 6 (1998), pp. 25-29
[32.]
M. Cueto, M.J. Sánchez, L. Molto, J.A. Miranda, A.J. Herruzo, A. Ruiz Bravo, et al.
Efficacy of a universal screening program for the prevention of neonatal group B streptococcal disease.
Eur J Clin Microbiol Infect Dis, 14 (1995), pp. 810-812
[33.]
G.J. Gilson, F. Christensen, H. Romero, K. Bekes, L. Silva, C.R. Qualls.
Prevention of group B streptococcus early-onset neonatal sepsis: Comparison of the Center for Disease Control and prevention screening-based protocol to a risk-based protocol in infants at greater than 37 weeks’ gestation.
J Perinatol, 20 (2000), pp. 491-495
[34.]
L.C. Paoletti, L.C. Madoff.
Vaccines to prevent neonatal GBS infection.
Seminars in Neonatology, 7 (2002), pp. 315-323
[35.]
Y. Hennequin, L. Tecco, A. Vokaer.
Use of chlorhexidine during labor: How effective against neonatal group B streptococci colonization?.
Acta Obstet Gynaecol Scand, 74 (1995), pp. 168
[36.]
B. Stray-Pedersen, T. Bergan, A. Hafstad, E. Normann, J. Grogaard, M. Vangdal.
Vaginal disinfection with chlorhexidine during childbirth.
Int J Antimicrob Agents, 12 (1999), pp. 245-251
[37.]
H.S. Jafari, A. Schuchat, R. Hilsdon, C.G. Whitney, K.E. Toomey, J.D. Wenger.
Barriers to prevention of perinatal Group B streptococcal disease.
Pediatr Infect Dis J, 14 (1995), pp. 662-667
[38.]
C.G. Whitney, B.D. Plikaytis, W.S. Gozansky, J.D. Wenger, A. Schauchat.
Prevention practices for perinatal group B streptococcal disease: A multi-state surveillance analysis.
Obstet Gynecol, 89 (1997), pp. 28-32
[39.]
A. Andreu, E. Ortega, A. Planes, S. Salcedo.
Evolución de la sepsis perinatal por Escherichia coli en la era de la profilaxis del estreptococo de grupo B.
Med Clin (Barc), 117 (2001), pp. 521-524
[40.]
R.S. Baltimore, S.M. Huie, J.I. Meek, A. Schuchat, K.L. O’Brien.
Early-onset neonatal sepsis in the era of group B streptococcal prevention.
Pediatrics, 108 (2001), pp. 1094-1098
[41.]
K.T. Chen, R.E. Tuomala, A.P. Cohen, E.C. Eichenwald, E. Lieberman.
No increase in rates of early-onset neonatal sepsis by non-group B Streptococcus or ampicillin-resistant organisms.
Am J Obstet Gynecol, 85 (2001), pp. 854-858
[42.]
E.M. Levine, V. Ghai, J.J. Barton, C.M. Strom.
Intrapartum antibiotic prophylaxis increases the incidence of gram-negative neonatal sepsis.
Infect Dis Obstet Gynecol, 7 (1999), pp. 210-213
[43.]
C.V. Towers, M.H. Carr, G. Padilla, T. Asrat.
Potential consequences of widespread use of ampicillin.
Am J Obstet Gynecol, 179 (1998), pp. 879-883
[44.]
A. Schuchat, S.S. Zywicki, M.J. Dinsmoor, B. Mercer, J. Romaguera, M.J. O’Sullivan, et al.
Risk factors and opportunities for prevention of early-onset neonatal sepsis: A multicenter case-control study.
Pediatrics, 105 (2000), pp. 21-26
[45.]
B.J. Stoll, N. Hansen, A.A. Fanaroff, L.L. Wright, W.A. Carlo, R.A. Ehrenkranz, et al.
Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants.
N Engl J Med, 347 (2002), pp. 240-247
[46.]
J. Bosch Mestres, A. Palau Charles, L. Serra Azuara, E. Álvarez Domínguez, M.C. Ricart Costa, R. Ros Vallverdu, et al.
Sepsis neonatal precoz por Streptococcus agalactiae. Estudio de diez años (1985-1994) y eficacia de la profilaxis intraparto.
An Esp Pediatr, 46 (1997), pp. 272-276
[47.]
Centers for Disease Control and Prevention. Group B streptococcal disease.United States, 1998-1999.
MMWR 49, 35 (2000), pp. 793-796
[48.]
H.E. Jeffery, M. Moses Lahra.
Eight-year outcome of universal screening and intrapartum antibiotics for maternal group B streptococcal carriers.
Pediatrics, 101 (1998), pp. E2
[49.]
American College of Obstetrics and Gynecologists. Prevention of early-onset group B streptococcal disease in newborns. ACOG Committee Opinion 279. December 2002.
Obstetrics-Gynecology, 100 (2002), pp. 1405-1412
[50.]
E. García Gil, M.C. Rodríguez, R. Bartolomé, B. Bejarano, L. Cabero, A. Andreu.
Evaluation of the Granada agar plate for detection of vaginal and rectal group B streptococci in pregnant women.
J Clin Microbiol, 37 (1999), pp. 2648-2651
[51.]
M. De la Rosa, D. Villarreal, D. Vega, C. Miranda, A. Martínez Brocal.
Granada Medium for detection and identification of Group B streptococci.
J Clin Microbiol, 18 (1983), pp. 779-785
[52.]
M. Rosa, M. Pérez, C. Carazo, J.I. Peis, L. Pareja, L. Hernández.
New Granada Medium for detection and Identification of group B streptococci.
J Clin Microbiol, 30 (1992), pp. 1019-1021
[53.]
M. Rosa-Fraile, J. Rodríguez-Granger, M. Cueto-López, A. Sampedro, E. Biel Gaye, J.M. Haro, et al.
Use of Granada Medium to detect group B streptococcal colonization in pregnant women.
J Clin Microbiol, 37 (1999), pp. 2674-2677
[54.]
E.L. Kaplan.
Recent evaluation of antimicrobial resistance in b-hemolytic streptococci.
Clin Infec Dis, 24 (1997), pp. 89-92
[55.]
Food and Drug Administration. FDA safety alert: Risks of devices for direct detection of group B streptococcal antigen. March, 24. 1997
[56.]
R. Samadi, A. Stek, J.S. Greenspoon.
Evaluation of a rapid optical immunoassay-based test for group B streptococcus colonization in intrapartum patients.
J Matern Fetal Med, 10 (2001), pp. 203-208
[57.]
D. Ke, M.G. Bergeron.
Molecular methods for rapid detection of group B streptococci.
Expert Rev Mol Diagn, 1 (2001), pp. 175-181
[58.]
M.A. Blanco Galán.
Microbiología de la Infección Perinatal.
Procedimientos en Microbiología Clínica No. 13,
[59.]
P.B. Mead.
Infection of the female pelvis.
Principles and Practice of Infectious Diseases. 5th. ed, pp. 1235-1243
[60.]
B. Aracil, M. Miñambres, J.C. Oteo, M. De la Rosa, J.L. Gomes-Garcés, J.I. Alos.
Susceptibility of strains of Streptococcus agalactiae to macrolides and lincosamines, phenotypic patterns and resistance genes.
Clin Microbiol Infect, 8 (2002), pp. 745-748
[61.]
P. Bromberger, J.M. Lawrence, D. Braun, B. Saunders, R. Contreras, D.B. Petitti.
The influence of intrapartum antibiotics on the clinical spectrum of early-onset group B streptococcal infection in term infants.
Pediatrics, 106 (2000), pp. 244-250
[62.]
S.R. Allen.
Management of asymptomatic term neonates whose mothers received intrapartum antibiotics. Part 1: Rationale for intrapartum antibiotic therapy.
Clin Pediatr, 36 (1997), pp. 563-568
[63.]
S.R. Allen.
Management of asymptomatic term neonates whose mothers received intrapartum antibiotics. Part 2: Diagnostic tests and management strategies.
Clin Pediatr, 36 (1997), pp. 617-624
[64.]
J.D. Siegel, N.B. Cushion.
Prevention of early-onset group B streptococcal disease: Another look at single-dose penicillin at birth.
Obstet Gynecol, 87 (1996), pp. 692-698
Copyright © 2003. Elsevier España, S.L.. Todos los derechos reservados
Opciones de artículo
Herramientas
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos